183 related articles for article (PubMed ID: 1355018)
21. Practical selection of antiemetics.
Flake ZA; Scalley RD; Bailey AG
Am Fam Physician; 2004 Mar; 69(5):1169-74. PubMed ID: 15023018
[TBL] [Abstract][Full Text] [Related]
22. Optimizing antiemetic therapy in multiple-day and multiple cycles of chemotherapy.
Ellebaek E; Herrstedt J
Curr Opin Support Palliat Care; 2008 Mar; 2(1):28-34. PubMed ID: 18685391
[TBL] [Abstract][Full Text] [Related]
23. A review of antiemetic drugs.
Bennett IE
J Am Podiatry Assoc; 1975 Mar; 65(3):228-32. PubMed ID: 234492
[No Abstract] [Full Text] [Related]
24. [Chemotherapy induced emesis: pathophysiology and prevention].
Mailliez A; Bonneterre J
Bull Cancer; 2010 Feb; 97(2):233-43. PubMed ID: 20051348
[TBL] [Abstract][Full Text] [Related]
25. Antiemetic drugs.
Cranwell-Bruce L
Medsurg Nurs; 2009; 18(5):309-13; quiz 314. PubMed ID: 19927970
[No Abstract] [Full Text] [Related]
26. Antiemetic therapy.
Axelrod RS
Compr Ther; 1997 Aug; 23(8):539-45. PubMed ID: 9283743
[TBL] [Abstract][Full Text] [Related]
27. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
28. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?
Schwartzberg LS
Oncology (Williston Park); 2007 Jul; 21(8):946-53; discussion 954, 959, 962 passim. PubMed ID: 17715696
[TBL] [Abstract][Full Text] [Related]
30. Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics.
May MB; Glode AE
Cancer Manag Res; 2016; 8():49-55. PubMed ID: 27274310
[TBL] [Abstract][Full Text] [Related]
31. Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting.
Addelman M; Erlichman C; Fine S; Warr D; Murray C
J Clin Oncol; 1990 Feb; 8(2):337-41. PubMed ID: 2153767
[TBL] [Abstract][Full Text] [Related]
32. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
33. [Medical treatment of chemotherapy-induced nausea and vomiting].
Herrstedt J
Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
[TBL] [Abstract][Full Text] [Related]
34. The vomiting patient.
Wyman JB; Wick MR
Am Fam Physician; 1980 Feb; 21(2):139-43. PubMed ID: 6101514
[TBL] [Abstract][Full Text] [Related]
35. Optimising antiemetic therapy: what are the problems and how can they be overcome?
Aapro M
Curr Med Res Opin; 2005 Jun; 21(6):885-97. PubMed ID: 15969889
[TBL] [Abstract][Full Text] [Related]
36. The emerging role of cannabinoid neuromodulators in symptom management.
Davis M; Maida V; Daeninck P; Pergolizzi J
Support Care Cancer; 2007 Jan; 15(1):63-71. PubMed ID: 17139494
[TBL] [Abstract][Full Text] [Related]
37. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
Goodman M
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
[TBL] [Abstract][Full Text] [Related]
38. Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
Nolte MJ; Berkery R; Pizzo B; Baltzer L; Grossano D; Lucarelli CD; Kris MG
J Clin Oncol; 1998 Feb; 16(2):771-8. PubMed ID: 9469369
[TBL] [Abstract][Full Text] [Related]
39. Prevention of postoperative nausea and vomiting.
Frizelle HP
Ir Med J; 2006 Jan; 99(1):28. PubMed ID: 16506691
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
